galactosamine has been researched along with b 1287 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, H; Kawaratani, H; Kitazawa, T; Tsujimoto, T | 2 |
2 other study(ies) available for galactosamine and b 1287
| Article | Year |
|---|---|
Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Galactosamine; Lipid A; Liver Failure, Acute; Male; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2009 |
Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Disease Models, Animal; Galactosamine; Injections, Intravenous; Lipid A; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Rats; Rats, Wistar; Time Factors; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2010 |